Program

Home

C. Flexner: Pharmacology of Aging

Website foto Flexner

Charles W. Flexner, M.D is Professor of Medicine in the Divisions of Clinical Pharmacology and Infectious Diseases, and Professor of Pharmacology and Molecular Sciences in the Johns Hopkins University School of Medicine. He is also Professor of International Health in the Johns Hopkins University Bloomberg School of Public Health. Dr. Flexner is Associate Vice-Chair for
Charles W. Flexner, M.D., is Professor of Medicine in the Divisions of Clinical Pharmacology and Infectious Diseases, and Professor of Pharmacology and Molecular Sciences in the Johns Hopkins University School of Medicine.  He is also Professor of International Health in the Johns Hopkins University Bloomberg School of Public Health.  Dr. Flexner is Associate Vice-Chair for Academic Fellowship Programs in the Department of Medicine, and Associate Director of the Graduate Training Program in Clinical Investigation of the Johns Hopkins University School of Medicine and School of Public Health.  He is Associate Program Director for the Johns Hopkins University General Clinical Research Center (GCRC), where he directs the Adult Outpatient GCRC Clinic.  Dr. Flexner currently serves as the Principal Investigator for the Johns Hopkins University AIDS Clinical Trials Unit (ACTU) supported by the NIH. He was Chair of the National AIDS Clinical Trials Group (ACTG) Pharmacology Committee from 1993-1995.  Dr. Flexner was elected President of the American Federation for Medical Research (AFMR) in 1999, and served as President of the AFMR Foundation until 2002.  In this capacity he helped to found the annual conjoint Clinical Research meetings that bring together six organizations with an interest in human subjects research.  He was Vice-President of the American Society for Clinical Pharmacology and Therapeutics from 2001-2002, and has served two terms on the Board of Directors of that Society.  He currently serves on the editorial boards of eight scientific journals.  He served as a consultant on FDA reform to the United States House of Representatives, and has served on several FDA Advisory Committees. From 2003-2006, he chaired the Dean’s Task Force on Competencies and Curricula for Graduate Medical Education. He received the Professor’s Award for Distinction in Teaching at Johns Hopkins in 2000.  His current research focuses on the basic and clinical pharmacology of drugs for HIV infection and AIDS.
  He is Associate Program Director for the Johns Hopkins University General Clinical Research Center (GCRC), where he directs the Adult Outpatient GCRC Clinic.  Dr. Flexner currently serves as the Principal Investigator for the Johns Hopkins University AIDS Clinical Trials Unit (ACTU) supported by the NIH. He was Chair of the National AIDS Clinical Trials Group (ACTG) Pharmacology Committee from 1993-1995.  Dr. Flexner was elected President of the American Federation for Medical Research (AFMR) in 1999, and served as President of the AFMR Foundation until 2002.  In this capacity he helped to found the annual conjoint Clinical Research meetings that bring together six organizations with an interest in human subjects research.  He was Vice-President of the American Society for Clinical Pharmacology and Therapeutics from 2001-2002, and has served two terms on the Board of Directors of that Society.  He currently serves on the editorial boards of eight scientific journals.  He served as a consultant on FDA reform to the United States House of Representatives, and has served on several FDA Advisory Committees. From 2003-2006, he chaired the Dean’s Task Force on Competencies and Curricula for Graduate Medical Education. He received the Professor’s Award for Distinction in Teaching at Johns Hopkins in 2000.  His current research focuses on the basic and clinical pharmacology of drugs for HIV infection and AIDS.